Rubric Capital Management LP Trevi Therapeutics, Inc. Transaction History
Rubric Capital Management LP
- $3.59 Billion
- Q3 2024
A detailed history of Rubric Capital Management LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 5,026,931 shares of TRVI stock, worth $21.5 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
5,026,931
Previous 5,026,931
-0.0%
Holding current value
$21.5 Million
Previous $15 Million
12.08%
% of portfolio
0.47%
Previous 0.44%
Shares
4 transactions
Others Institutions Holding TRVI
# of Institutions
94Shares Held
57.1MCall Options Held
136KPut Options Held
5.4K-
Nea Management Company, LLC Timonium, MD11.4MShares$48.6 Million2.9% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$31.5 Million1.33% of portfolio
-
Viking Global Investors LP4.4MShares$18.8 Million0.06% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$14.6 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$13.9 Million0.0% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $249M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...